第87回日本生化学会大会
Oct 15 - Oct 18, 2014Kyoto International Conference Center / Grand Prince Hotel Kyoto
第87回日本生化学会大会
Oct 15 - Oct 18, 2014Kyoto International Conference Center / Grand Prince Hotel Kyoto
[2PL1]Tofacitinib (CP-690,550): A First-In-Class Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis
○Flanagan Mark E.(Pfizer Worldwide Medicinal Chemistry)
Keywords:
tofacitinib,CP-690,550,Janus kinase,JAK/STAT,JAK pathways
Password required to view
Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.
You need the membership number and password to access the member page. Please contact the journal office for any inquiries.
Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934
You can access the abstracts without credentials by accessing them via the member page.
You need the membership number and password to access the member page. Please contact the journal office for any inquiries.
Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934